Skip to main content
NIH funding notice RFA-NS-21-006

Mechanisms of Pathological Spread of Abnormal Proteins in LBD and FTD (R01 Clinical Trial Not Allowed)

Closed on October 27, 2020.

Posted
August 6, 2020
Close date
October 27, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
2
2 new
Median first-year cost
$1,797,089
$3,594,178 in all
Institutions
2
2 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. OREGON HEALTH & SCIENCE UNIVERSITY1
  2. SCRIPPS RESEARCH INSTITUTE, THE1

Most frequent study sections

  1. Special Emphasis Panel (ZRG1 BDCN-B (55))2
2 awards under RFA-NS-21-006 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2021S-Nitrosylation-Dependent Pathological Spread of Abnormal Proteins in Frontotemporal Dementia and Lewy Body Dementia1RF1NS123298-01Nakamura, TomohiroSCRIPPS RESEARCH INSTITUTE, THE, CAFirst-year cost $2,081,944Study section ZRG1
FY2021Mechanisms of spreading proteinopathy in Lewy Body Dementia1RF1NS123457-01Unni, VivekWoltjer, Randall LOREGON HEALTH & SCIENCE UNIVERSITY, ORFirst-year cost $1,512,234Study section ZRG1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.